Research location
Meldola
FC, Italy
Advertisement
Research activity in Meldola
FC, ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 55 trials and 55 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Meldola
55 linked trials · page 1 of 2Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT07222566 · 2026-01-06 · 1 site observation
RECRUITING
Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLCNCT07356544 · 2025-08-12 · 1 site observation
RECRUITING
Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate CancerNCT07093801 · 2025-07-30 · 1 site observation
RECRUITING
Whole Body MRI in OncologyNCT06895291 · 2023-10-26 · 1 site observation
RECRUITING
Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)NCT05893381 · 2023-06-27 · 1 site observation
RECRUITING
A Multicenter Open-label Phase II Study of Cemiplimab Plus Chemotherapy, Selected on the Basis of Baseline Cytidine Deaminase Activity, in Advanced Squamous Non-small Cell Lung CancerNCT07418931 · 2026-05-01 · 1 site observation
NOT_YET_RECRUITING
Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)NCT03454750 · 2022-10-25 · 1 site observation
COMPLETED
Roll-over Study to Allow Continued Access to RibociclibNCT05161195 · 2022-07-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Horse-assisted Interventions in an Oncological CentreNCT07831460 · 2021-06-14 · 1 site observation
COMPLETED
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCNCT04821622 · 2021-05-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCNCT04446117 · 2020-10-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer.NCT04775602 · 2020-07-31 · 1 site observation
COMPLETED
Best EGFR-TKI Sequence in NSCLC Harboring EGFR MutationsNCT04811001 · 2020-06-12 · 1 site observation
UNKNOWN
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN LossNCT04251533 · 2020-06-08 · 1 site observation
TERMINATED
Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.NCT04345315 · 2020-03-27 · 1 site observation
UNKNOWN
Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior TherapiesNCT03546426 · 2019-12-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Acupuncture And Inflammatory Status In Breast Cancer Patients With Climateric Syndrome.NCT07137221 · 2019-07-02 · 1 site observation
COMPLETED
Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) BrachytherapyNCT03553212 · 2018-10-30 · 1 site observation
TERMINATED
Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging.NCT03465579 · 2018-05-23 · 1 site observation
TERMINATED
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-ANCT03447769 · 2018-03-16 · 1 site observation
TERMINATED
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced MalignanciesNCT03317496 · 2017-12-21 · 1 site observation
TERMINATED
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCNCT03395197 · 2017-12-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsNCT03170960 · 2017-09-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate CancerNCT03230734 · 2017-09-01 · 1 site observation
UNKNOWN
CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDONCT03227328 · 2017-08-02 · 1 site observation
COMPLETED
Investigation of PSMA PET/CT as an Imaging Biomarker in Solid TumorsNCT03453528 · 2017-07-04 · 1 site observation
COMPLETED
PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC PatientsNCT03064854 · 2017-05-24 · 1 site observation
TERMINATED
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)NCT03036488 · 2017-03-07 · 1 site observation
COMPLETED
Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase ExpressionNCT02919462 · 2016-03-01 · 1 site observation
TERMINATED
68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically TreatedNCT02920229 · 2015-11-01 · 1 site observation
COMPLETED
A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET AmplificationNCT02468661 · 2015-09-23 · 1 site observation
TERMINATED
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.NCT02437318 · 2015-07-23 · 1 site observation
COMPLETED
Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)NCT02414139 · 2015-06-11 · 1 site observation
COMPLETED
Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)NCT02299505 · 2015-04-09 · 1 site observation
COMPLETED
A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLCNCT02364999 · 2015-04-01 · 1 site observation
COMPLETED
Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT MethylationNCT02477813 · 2015-01-01 · 1 site observation
TERMINATED
A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast CancerNCT02488564 · 2014-12-17 · 1 site observation
COMPLETED
CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.NCT03381326 · 2014-12-15 · 1 site observation
UNKNOWN
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast CancerNCT02278120 · 2014-11-20 · 1 site observation
COMPLETED
Safety Study of Continued Enzalutamide Treatment In Prostate Cancer PatientsNCT01995513 · 2013-10-22 · 1 site observation
COMPLETED
CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast CancerNCT02918084 · 2013-06-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)NCT02000375 · 2013-03-01 · 1 site observation
TERMINATED
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)NCT01740427 · 2013-02-22 · 1 site observation
COMPLETED
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORiNCT01633060 · 2012-10-03 · 1 site observation
TERMINATED
Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase InhibitorNCT01610284 · 2012-08-07 · 1 site observation
COMPLETED
Study of INC280 in Patients With c-MET Dependent Advanced Solid TumorsNCT01324479 · 2012-02-29 · 1 site observation
COMPLETED
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate CancerNCT01212991 · 2010-09-16 · 1 site observation
COMPLETED
A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.NCT02225652 · 2010-09-01 · 1 site observation
COMPLETED
A Dose Escalation Study in Adult Patients With Advanced Solid MalignanciesNCT01004224 · 2009-12-11 · 1 site observation
COMPLETED
A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast CancerNCT02131506 · 2009-12-01 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.